Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program.
Houghton PJ, Morton CL, Gorlick R, Lock RB, Carol H, Reynolds CP, Kang MH, Maris JM, Keir ST, Kolb EA, Wu J, Wozniak AW, Billups CA, Rubinstein L, Smith MA.
Houghton PJ, et al. Among authors: kang mh.
Mol Cancer Ther. 2010 Jan;9(1):101-12. doi: 10.1158/1535-7163.MCT-09-0952. Epub 2010 Jan 6.
Mol Cancer Ther. 2010.
PMID: 20053767
Free PMC article.